Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03837899
Brief Title: Durvalumab and Tremelimumab for Pediatric Malignancies

First Submitted : January 24, 2019
First Submitted that Met QC Criteria : February 8, 2019
First Posted : February 12, 2019

Last Update Submitted that Met QC Criteria : March 19, 2019
Last Update Posted : March 21, 2019